Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immunovia AB (IMMVF)
OTHER OTC:IMMVF
Holding IMMVF?
Track your performance easily
IMMVF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.15 - $2.36
Previous Close$0.15
Volume325.00
Average Volume (3M)N/A
Market Cap
$9.82M
Enterprise Value-$1.15M
Total Cash (Recent Filing)kr158.84M
Total Debt (Recent Filing)kr39.87M
Price to Earnings (P/E)―
Beta0.08
Next Earnings
Nov 27, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.12
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.23
R-Squared0.02
Alpha-0.11
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)97.22
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
― Other Institutional Investors
100.00% Public Companies and
Individual Investors
IMMVF FAQ
What was Immunovia AB’s price range in the past 12 months?
Immunovia AB lowest stock price was $0.15 and its highest was $2.36 in the past 12 months.
What is Immunovia AB’s market cap?
Currently, no data Available
When is Immunovia AB’s upcoming earnings report date?
Immunovia AB’s upcoming earnings report date is Nov 27, 2024 which is in 13 days.
How were Immunovia AB’s earnings last quarter?
Immunovia AB released its earnings results on Aug 05, 2024. The company reported -$0.026 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.026.
Is Immunovia AB overvalued?
According to Wall Street analysts Immunovia AB’s price is currently Overvalued.
Does Immunovia AB pay dividends?
Immunovia AB does not currently pay dividends.
What is Immunovia AB’s EPS estimate?
Immunovia AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Immunovia AB have?
Immunovia AB has 169,711,470 shares outstanding.
What happened to Immunovia AB’s price movement after its last earnings report?
Immunovia AB reported an EPS of -$0.026 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Immunovia AB?
Currently, no hedge funds are holding shares in IMMVF
---
Immunovia AB Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-93.49%
12-Months-Change
Fundamentals
Return on Equity
-154.69%
Trailing 12-Months
Asset Growth
-68.74%
Trailing 12-Months
Company Description
Immunovia AB
Immunovia AB molecular diagnostic company. It develops and commercializes diagnostic tools for complex forms of cancer and autoimmune diseases. Its technology platform IMMray (TM), is based on antibody microarray analysis.
---
IMMVF Company Deck
---
IMMVF Earnings Call
Q2 2024
0:00 / 0:00
---
Technical Analysis
---